Primary Navigation for the CDC Website
CDC en Español
Vaccine Safety
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
 Vaccine Safety Basics
bullet Information for Parents
bullet Why It's Important to Monitor Vaccine Safety
bullet How Vaccines Are Tested and Monitored
bullet Common Questions
bullet Vaccine Safety Concerns
bullet History of Vaccine Safety

 Public Health Activities
bullet Vaccine Adverse Event Reporting System (VAERS)
bullet Vaccine Safety Datalink (VSD) Project
bullet Clinical Immunization Safety Assessment (CISA) Network
bullet Brighton Collaboration
bullet Vaccine Technology
bullet Emergency Preparedness
bullet Publications
bullet 2008
bullet 2007
bullet 2006
bullet Scientific Agenda

2006 Scientific Articles

Bines JE, Liem NT, Justice F, Son TN, Carlin JB, de Campo M, Jamsen K, Mulholland K, Barnett P, Barnes GL. Validation of a clinical case definition for acute intussusception in infants in Viet Nam and Australia.* Bulletin of the World Health Organization 2006;84(7):569–575.

Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, October 2005–February 2006. MMWR 2006;55(13):364–366.

Centers for Disease Control and Prevention (CDC). Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005–September 2006. MMWR 2006;55(41):1120–1124.

DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; VAERS Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 2006;24(6):703–707.

France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, Shay D, Weintraub E, Fry AM, Black SB, Shinefield HR, Mullooly JP, Jackson LA. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants.* Archives of Pediatrics & Adolescent Medicine 2006;160(12):1277–1283.

Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Journal of Clinical Epidemiology 2006;59(8):808–818.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 2006;296(16):1990–1997.

Iskander J, Pool V, Zhou W, English-Bullard R; The VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting System. Drug Safety 2006;29(5):375–384.

Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D, Baggs J, Mullooly J, Black S, Shay DK. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine 2006;24(2):151–156.

Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, Belongia E, Zangwill KM, Mullooly J, Nordin J, Marcy SM, DeStefano F. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 2006;118(5):2032–2037.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Wei F, Mullooly JP, Black S, Shay DK, Kolczak M, Lieu TA; Vaccine Safety Datalink Team. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatrics 2006;6:31.

Muralles AA, Ray P, Black S, Shinefield H, Casey CG, Campbell S, Chen RT; Clinical Immunization Safety Assessment Network. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine 2006;24(4):476–484.

Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Noelle-Angelique MM, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerging Infectious Diseases 2006;12(10):1548–1558.

Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, Shinefield H, Marcy M, Huff K, Ward J, Mullooly J, Chen R, Davis R; Vaccine Safety Datalink Group. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatric Infectious Disease Journal 2006;25(9):768–773.

Tapiainen T, Bär G, Bonhoeffer J, Heininger U. Evaluation of The Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine 2006;24(9):1483–1487.

Varricchio F, Reed J; VAERS Working Group. Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS). Southern Medical Journal 2006;99(5):486–489.

Vermeer-de Bondt PE, Dzaferagić A, David S, van der Maas NA. Performance of The Brighton Collaboration case definition for hypotonic–hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands. Vaccine 2006;24(49–50):7066–7070.

Woo EJ, Ball R, Landa R, Zimmerman AW, Braun MM; VAERS Working Group. Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Autism 2007;11(4):301–310.

Woo EJ, Miller NB, Ball R; VAERS Working Group. Adverse events after hepatitis A B combination vaccine. Vaccine 2006;24(14):2685–2691.

*Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.

Page last reviewed: January 29, 2008 (archived document)
Page last updated: January 29, 2008
Content source: Immunization Safety Office, Office of the Chief Science Officer

  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
Public Inquiries: 1-800-CDC-INFO (232-4636); 1-888-232-6348 (TTY)
USA.govDHHS Department of Health
and Human Services